Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1766352

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1766352

Remote Patient Monitoring Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Remote Patient Monitoring Devices Market was valued at USD 17 billion in 2024 and is estimated to grow at a CAGR of 13.5% to reach USD 57.5 billion by 2034. This rapid growth is largely driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and chronic kidney disease. Government initiatives supporting digital health and the widespread adoption of RPM devices are fueling the market expansion. These devices offer real-time health data collection, which enables early detection of health irregularities and timely interventions, improving patient outcomes. RPM devices, which range from wearable sensors to handheld instruments, track various health metrics, including heart rate, blood glucose, and blood pressure.

Remote Patient Monitoring Devices Market - IMG1

These devices transmit data wirelessly to healthcare professionals, allowing continuous health monitoring, enhancing patient engagement, and supporting value-based healthcare models. Furthermore, advancements in wearable technologies, sensor accuracy, and AI integration are improving the efficiency and customization of monitoring solutions, even in developing nations. As healthcare systems evolve with digital tools, the RPM market continues to grow, benefiting from technological advancements and increasing demand for remote care.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$17 Billion
Forecast Value$57.5 Billion
CAGR13.5%

The cardiac monitoring segment generated USD 4 billion in 2024 and is expected to grow at a CAGR of 13.8% through 2034. The rising demand for cardiac monitoring devices is driven by advancements in technology, which have improved the precision and reliability of these tools. These devices allow continuous monitoring of vital metrics such as heart rate, rhythm, and other cardiac indicators, enabling rapid intervention when necessary.

The diabetes segment held a significant share of the market at 22.7% in 2024. Continuous monitoring of key health parameters, such as blood glucose levels and insulin management, is essential for diabetes care, and RPM devices facilitate real-time tracking, early detection of complications, and timely intervention, thereby preventing severe outcomes and hospitalizations.

U.S. Remote Patient Monitoring Devices Market was valued at USD 6.3 billion in 2024 The country's expansion in this sector is fueled by the rising prevalence of chronic diseases, such as hypertension and cardiovascular conditions, which require continuous monitoring. Remote monitoring solutions like smart blood pressure monitors and pulse oximeters are enabling patients and healthcare providers to track these conditions in real-time, contributing to market growth.

The key players in the Remote Patient Monitoring Devices Industry include Johnson & Johnson, Siemens Healthineers, Medtronic, OMRON, VitalConnect, Abbott Laboratories, F. Hoffmann-La Roche, and others. These companies are instrumental in shaping the industry by providing advanced remote monitoring solutions that enhance patient care and improve clinical outcomes. To strengthen their position in the RPM devices market, companies are focusing on multiple strategies. They are heavily investing in the research and development of innovative technologies such as AI-driven monitoring systems and improved wearable devices. Strategic partnerships with healthcare providers, hospitals, and telemedicine platforms are enhancing their reach. Companies are also focusing on expanding their global presence by offering products suited to different regional healthcare needs. Additionally, many players are integrating telehealth services with RPM devices to deliver more comprehensive care.

Product Code: 5563

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product
    • 2.2.3 Application
    • 2.2.4 End use
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Factor affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases across the globe
      • 3.2.1.2 Growing disposable income and healthcare expenditure in emerging countries
      • 3.2.1.3 Technological advancement in developed nations
      • 3.2.1.4 Growing adoption of remote patient monitoring devices
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulatory framework
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing adoption of AI-powered predictive monitoring tools
      • 3.2.3.2 Emergence of wearable biosensors for continuous, real-time health tracking
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Patent analysis
  • 3.8 Gap analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard
  • 4.7 Key developments
    • 4.7.1 Mergers & acquisitions
    • 4.7.2 Partnerships & collaborations
    • 4.7.3 New product launches
    • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cardiac monitoring devices
  • 5.3 Blood pressure monitoring devices
  • 5.4 Neurological monitoring devices
  • 5.5 Respiratory monitoring devices
  • 5.6 Multiparameter monitoring devices
  • 5.7 Blood glucose monitoring devices
  • 5.8 Fetal and neonatal monitoring devices
  • 5.9 Sleep monitoring devices
  • 5.10 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiovascular diseases
  • 6.3 Cancer
  • 6.4 Diabetes
  • 6.5 Neurological disorders
  • 6.6 Infectious diseases
  • 6.7 Respiratory diseases
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Home-care settings
  • 7.3 Long-term care
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Poland
    • 8.3.8 Switzerland
    • 8.3.9 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Thailand
    • 8.4.7 Indonesia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Colombia
    • 8.5.5 Chile
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Israel

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Baxter International
  • 9.3 Boston Scientific
  • 9.4 Cerner
  • 9.5 DexCom
  • 9.6 F. Hoffmann-La Roche
  • 9.7 General Electric Company
  • 9.8 Johnson & Johnson
  • 9.9 Koninklijke Philips
  • 9.10 Medtronic
  • 9.11 OMRON
  • 9.12 Siemens Healthineers
  • 9.13 VitalConnect
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!